Other factors that increase risk include gallbladder disease, very high triglyceride levels, and heavy alcohol use
Take growth hormone secretagogues as an example
However, retatrutide has higher discontinuation rates and an emerging safety signal (dysesthesia) not seen with the other medications
CrossRef Nonlinear Association Between BMI and Depression Among Nonalcoholic Fatty Liver Disease: NHANES (20172018) Hui Peng, Dan Zhou, Yuan Dai, Weifeng Chen, Tauheed Ishrat Behavioural Neurology .2025;[Epub] CrossRef Analysis of gastric electrical rhythm in patients with metabolic dysfunction-associated steatotic liver disease and type 2 diabetes mellitus Xi-Xi Wang, Chun Yan, Su-Juan Wang, Hong Zhu, Chang-Chun Cao, Li Wu, Shuang Wang, Ji Hu, Hong-Hong Zhang World Journal of Hepatology .2025;[Epub] CrossRef Gradual DNA methylation changes reveal transcription factors implicated in metabolic dysfunction-associated steatotic liver disease progression and epigenetic age acceleration Evelien Van Dijck, Steven Van Laere, Emilie Logie, Steven Timmermans, Erik Fransen, Joe Ibrahim, Timothy J
This article focuses specifically on the topical serum format